These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 27126067
1. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii). Ujvari B, Hamede R, Peck S, Pemberton D, Jones M, Belov K, Madsen T. Sci Rep; 2016 Apr 29; 6():25093. PubMed ID: 27126067 [Abstract] [Full Text] [Related]
2. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils. Pye R, Hamede R, Siddle HV, Caldwell A, Knowles GW, Swift K, Kreiss A, Jones ME, Lyons AB, Woods GM. Biol Lett; 2016 Oct 29; 12(10):. PubMed ID: 28120799 [Abstract] [Full Text] [Related]
3. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM. Vaccine; 2015 Jun 12; 33(26):3016-25. PubMed ID: 25708088 [Abstract] [Full Text] [Related]
8. Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release. Pye R, Patchett A, McLennan E, Thomson R, Carver S, Fox S, Pemberton D, Kreiss A, Baz Morelli A, Silva A, Pearse MJ, Corcoran LM, Belov K, Hogg CJ, Woods GM, Lyons AB. Front Immunol; 2018 Mar 09; 9():259. PubMed ID: 29515577 [Abstract] [Full Text] [Related]
12. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii). Loh R, Hayes D, Mahjoor A, O'Hara A, Pyecroft S, Raidal S. Vet Pathol; 2006 Nov 09; 43(6):896-903. PubMed ID: 17099146 [Abstract] [Full Text] [Related]
14. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. Tovar C, Patchett AL, Kim V, Wilson R, Darby J, Lyons AB, Woods GM. PLoS One; 2018 Nov 09; 13(4):e0196469. PubMed ID: 29702669 [Abstract] [Full Text] [Related]
15. The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii). Patchett AL, Tovar C, Corcoran LM, Lyons AB, Woods GM. Dev Comp Immunol; 2017 Nov 09; 76():352-360. PubMed ID: 28689773 [Abstract] [Full Text] [Related]